ArticleInternational journal of clinical and experimental medicine2015

Short-term effect and adverse events of adalimumab versus placebo in inducing remission for moderate-to-severe ulcerative colitis: a meta-analysis.

Zheng Yang et al.PubMed ↗Full text ↗

No numbers read from the abstract.